The University of Queensland is one step closer to developing better mobile phone battery life, understanding the engineering of vaccines and creating stem cell therapies for Parkinson’s disease. The University’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has bought a $275,000 high performance parallel computer cluster that will support research stretching from the development of advanced materials for clean fuel, through to the engineering of new vaccines to develop anti-cancer drugs.
Centre for Theoretical and Computational Molecular Science Director Professor Debra Bernhardt said the new computer would focus on computational speed.
Jarrett Neil Ridlinghafer
Founder & CEO
Synapse Synergy Group, Inc.
LinkedIn Profile: LinkedIn.com/in/jnridlinghafer
Google +: https://plus.google.com/+JarrettNeilRidlinghafer